400 related articles for article (PubMed ID: 19562640)
1. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
3. Current practices for DNA sample collection and storage in the pharmaceutical industry, and potential areas for harmonization: perspective of the I-PWG.
Franc MA; Warner AW; Cohen N; Shaw PM; Groenen P; Snapir A
Clin Pharmacol Ther; 2011 Apr; 89(4):546-53. PubMed ID: 21368755
[TBL] [Abstract][Full Text] [Related]
4. Trial watch: personalized medicines in late-stage development.
Milne CP; Garafalo S; Bryan C; McKiernan M
Nat Rev Drug Discov; 2014 May; 13(5):324-5. PubMed ID: 24781541
[No Abstract] [Full Text] [Related]
5. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
6. [PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS].
Scheen AJ
Rev Med Liege; 2015; 70(5-6):237-41. PubMed ID: 26285445
[TBL] [Abstract][Full Text] [Related]
7. Toward personalized medicine in the neuropsychiatric field.
Wong EH; Fox JC; Ng MY; Lee CM
Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
[TBL] [Abstract][Full Text] [Related]
8. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
9. Clinical prediction rules: new opportunities for pharma.
Herscu P; Hoover TA; Randolph AG
Drug Discov Today; 2009 Dec; 14(23-24):1143-9. PubMed ID: 19853059
[TBL] [Abstract][Full Text] [Related]
10. A challenging drug development process in the era of personalized medicine.
Jørgensen JT
Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
[TBL] [Abstract][Full Text] [Related]
11. Developing pharmacogenetic evidence throughout clinical development.
Burns DK
Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
[TBL] [Abstract][Full Text] [Related]
12. [Personalized medicine--genomic phase].
Brdicka R
Cas Lek Cesk; 2009; 148(10):477-80. PubMed ID: 20662409
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine: changing the paradigm of drug development.
Couch RD; Mott BT
Methods Mol Biol; 2012; 823():367-78. PubMed ID: 22081358
[TBL] [Abstract][Full Text] [Related]
15. A piece in the puzzle of personalized medicine.
Kroemer HK; Meyer zu Schwabedissen HE
Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
[TBL] [Abstract][Full Text] [Related]
16. Dealing with the evidence dilemma in genomics and personalized medicine.
Khoury MJ
Clin Pharmacol Ther; 2010 Jun; 87(6):635-8. PubMed ID: 20485318
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging to biomarker development in neuroscience.
Frost JJ
Ann N Y Acad Sci; 2008 Nov; 1144():251-5. PubMed ID: 19076382
[TBL] [Abstract][Full Text] [Related]
18. Impact of personalized medicine on diagnostics and therapeutics.
Sitaraman R
Natl Med J India; 2010; 23(2):124. PubMed ID: 20925220
[No Abstract] [Full Text] [Related]
19. [Front-line drug discovery system for cancer].
Mizukami T
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
[TBL] [Abstract][Full Text] [Related]
20. HLA, immunogenetics, pharmacogenetics and personalized medicine.
Charron D
Vox Sang; 2011 Jan; 100(1):163-6. PubMed ID: 21175666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
